相关实验视频
Updated: Jul 23, 2025

13:10
DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
20.6K
对针对癌症的RNA疫苗进行图书统计分析
Xue Yang1, Jian Kang2, Zhaohui Xing2
1Blood Sample Collection, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Human vaccines & immunotherapeutics
|July 18, 2023
概括
这项图书统计研究揭示了针对癌症预防和治疗的RNA疫苗的日益增长的研究. 关键领域包括瘤抗原和脂质纳米颗粒,突出显示了该领域的新兴趋势.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 癌症对全球健康构成了重大挑战,推动了对新型治疗策略的研究.
- RNA疫苗已经成为癌症预防和治疗的有希望的方法.
- 缺乏一个图书统计分析来绘制RNA疫苗在瘤学中的研究格局.
研究的目的:
- 在癌症研究中对RNA疫苗进行文献分析.
- 总结知识结构并确定研究热点.
- 提供有关该领域研究趋势和发展的见解.
主要方法:
- 使用VOSviewers,CiteSpace和R包"bibliometrix"进行图书法分析.
- 数据来源于网络科学核心集合 (WoSCC) 的数据.
- 对1399篇出版物 (803篇原创文章,596篇评论) 的分析.
主要成果:
- 关于癌症RNA疫苗的出版物每年增加.
- 中国和美国是领先的国家;约翰内斯·古登堡大学梅因茨,NCI和杜克大学是关键机构.
- 免疫学的边界是著名的期刊;热门的关键词包括瘤抗原,脂质纳米粒子,新兴的角色和树突细胞.
结论:
- 针对癌症的RNA疫苗领域正在迅速扩大.
- 图书统计分析提供了关于研究趋势和合作的有价值的概述.
- 这项研究为基于RNA的癌症免疫疗法未来的研究提供了参考.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Cancer Vaccines
410
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
410
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K

